Releases New Report on the Antigout Drug Market 2020-2025 | Top Key Players - Novartis, Takeda, Aspen, Teijin Pharma, Horizon Pharma

The Global Antigout Drug Market is comprehensively and Insightful information in the report, taking into consideration various factors such as competition, regional growth, segmentation, and Antigout Drug Market size by value and volume. This is an excellent research study specially compiled to provide the latest insights into critical aspects of the Global Antigout Drug Market 2020-2025.

Overview of Global Antigout Drug Market:

This report studies the Global Antigout Drug Market over the forecast period of 2020 to 2025. The Global Antigout Drug Market is expected to grow at an impressive Compound Annual Growth Rate (CAGR) from 2020 to 2025.

According to the market report analysis, Antigout drugs correct the under excretion or overproduction of uric acid. These can effectively control hyperuricemia for a long term that is caused due to formation of uric acid from purines. The choice of uricosuric medicines or xanthine oxidase inhibitors is based on presence of tophi, history of renal calculi, patient’s age, renal function, and the level of urinary uric acid excretion. Gout is formed due to medical conditions including urinary tract stones, sweet's syndrome, sarcoidosis, reactive perforating collangenosis, pseudo gout prophylaxis, mania, linear IgA disease, leishmaniasis, hyperuricemia secondary to chemotherapy, high risk percutaneous trans-luminal angioplasty, heart failure, and gouty arthritis.

Available Exclusive Sample Copy of this Report @ https://www.businessindustryreports.com/sample-request/275343 .

The Global Antigout Drug Market is segmented on the basis of Type, Application and Region. Based on the Type, the Global Antigout Drug Market is sub-segmented into Febuxostat, Benzbromarone, Allopurinol, Colchicine and others. On the basis of Application, the Global Antigout Drug Market is classified into Acute Gout, Chronic Gout and others.

In terms of the geographic analysis, The Antigout Drug Market in North America is expected to grow at the highest CAGR during the forecast period. Moreover, the presence of major players in the Antigout Drug Market ecosystem results in the increasing adoption of these systems in North America.

Global Antigout Drug Market Objectives:

1 To provide detailed information regarding key factors (drivers, restraints, opportunities, and industry-specific challenges) influencing the growth of the Antigout Drug Market

2 To analyze and forecast the size of the Antigout Drug Market, in terms of value and volume

3 To analyze opportunities in the Antigout Drug Market for stakeholders and provide a competitive landscape of the market

4 To define, segment, and estimate the Antigout Drug Market based on deposit type and end-use industry

5 To strategically profile key players and comprehensively analyze their market shares and core competencies

6 To strategically analyze micromarkets with respect to individual growth trends, prospects, and contribution to the total market

7 To forecast the size of market segments, in terms of value, with respect to main regions, namely, Asia Pacific, North America, Europe, the Middle East & Africa, and South America

8 To track and analyze competitive developments, such as new product developments, acquisitions, expansions, partnerships, and collaborations in the Antigout Drug Market

Purchase this report online with 90 Pages, List of Tables & Figures and in-depth Table of Contents on “Global Antigout Drug Market Report 2020” @ https://www.businessindustryreports.com/buy-now/275343/single .

Top Leading Key Manufacturers are: Takeda, Aspen, heumann pharma, Teijin Pharma, Horizon Pharma, Novartis, WanBang, Jiangsu Hengrui Medicine, Rotamreddy, KPC Pharmaceuticals and others. New product launches and continuous technological innovations are the key strategies adopted by the major players.

Region segment: This report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of Antigout Drug in these regions, from 2013 to 2025 (forecast), covering: North America, Europe, Asia Pacific, Middle East & Africa and South America

Medical Industry News:

Novartis (October 05, 2020) - New Phase III analysis demonstrates Novartis Beovu showed improvement in best-corrected visual acuity in wet AMD patients with early persistent fluid - Novartis today announced that results of two new post-hoc analyses of the Phase III HAWK and HARRIER clinical trials in wet age-related macular degeneration (AMD) were presented at the EURETINA 2020 virtual congress. The first analysis demonstrated fewer Beovu (brolucizumab) patients had early persistent fluid, defined as the presence of intra-retinal fluid and/or sub-retinal fluid through week 12 of treatment, compared with aflibercept patients. For patients who did have early persistent fluid, those treated with Beovu achieved greater best-corrected visual acuity (BCVA) gains and greater reductions in central subfield thickness (CST) at week 96 versus those treated with aflibercept.

A second analysis showed Beovu was associated with better control of retinal fluid, as measured by achievement and maintenance of defined CST levels. In the study, more Beovu patients than aflibercept patients achieved CST control (80% vs. 69% at week 96 at a defined CST threshold of 320 µm, respectively). Patients who stayed longer in a controlled CST state had better visual gains compared with those who remained in an uncontrolled CST state. CST is a key indicator of fluid in the retina, and drying the retina is a core aim of treatment for wet AMD.

“The data presented at EURETINA suggests Beovu can better help patients who have persistent retinal fluid achieve disease control by reducing CST and improving their vision in the long term,” said Dirk Sauer, Global Head Development, Novartis Pharma Ophthalmology. “These results further strengthen our confidence in Beovu as an effective and important treatment option for wet AMD patients aiming to improve their vision.”

Novartis has nine podium presentations at the congress and is sponsoring a Beovu symposium and an independent medical education program conducted by EURETINA.

Grab Your Report at an Impressive Discount @ https://www.businessindustryreports.com/check-discount/275343 .

Major Points in Table of Contents:

Global Antigout Drug Market Report 2020

1 Antigout Drug Product Definition

2 Global Antigout Drug Market Manufacturer Share and Market Overview

2.1 Global Manufacturer Antigout Drug Shipments

2.2 Global Manufacturer Antigout Drug Business Revenue

2.3 Global Antigout Drug Market Overview

2.4 COVID-19 Impact on Antigout Drug Industry

3 Manufacturer Antigout Drug Business Introduction

3.1 Takeda Antigout Drug Business Introduction

3.2 Aspen Antigout Drug Business Introduction

3.3 heumann pharma Antigout Drug Business Introduction

3.4 Teijin Pharma Antigout Drug Business Introduction

3.5 Horizon Pharma Antigout Drug Business Introduction

3.6 Novartis Antigout Drug Business Introduction

………………. Request free sample to get a complete Table of Content

About us

BusinessindustryReports.com is a digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined – we want to help our clients envisage their business environment so that they are able to make informed, strategic, and therefore successful decisions for themselves.

Media Contact

Business Industry Reports

Pune – India

sales@businessindustryreports.com

+19376349940

This release was published on openPR.